Regeneron Pharmaceuticals Inc. buy Sanford C. Bernstein
Summary
This prediction is currently active. Since the start of the prediction for Regeneron Pharmaceuticals Inc. the price has only changed by -0.32%. This prediction currently runs until 27.08.26. The prediction end date can be changed by Sanford_C__Bernstein at any time. Sanford_C__Bernstein has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
Name | 1w |
---|---|
Regeneron Pharmaceuticals Inc. | -0.32% |
iShares Core DAX® | -0.545% |
iShares Nasdaq 100 | 0.626% |
iShares Nikkei 225® | -1.750% |
iShares S&P 500 | 0.882% |
Comments by Sanford_C__Bernstein for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Stopped prediction by Sanford_C__Bernstein for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
07.01.25
07.01.26
27.08.25
Regeneron Pharmaceuticals Inc.
12.03.24
12.03.25
13.03.25